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Estela Medrano’s scientific achievements were 
remarkable. They were always produced in an 
unpretentious, far from ambitious way. She was 
a devoted mother of four sons and a devoted 
scientist. Her work led to important discoveries, 
including the restriction point in the cell cycle 
(during her postdoctoral fellowship at Harvard) 
(Medrano and Pardee, 1980; Campisi et al., 
1982), cancer stem cells (a discovery made more 
than 20 years ago in Argentina and perhaps not 
fully recognized) (Resnicoff et al., 1987), and, 
more recently (within dermatology), impor-
tant molecular pathways in melanocyte aging. 
Her laboratory discovered that the oncogenic 
protein SKI is a major repressor of TGF-b growth 
inhibitory signals in melanoma (Xu et al., 2000).
I met Estela in 1984, just after I had 
graduated from college, at a conference on 
oncogenes in Buenos Aires. I observed Estela 
among a group of prominent international sci-
entists, humbly discussing her recent scientific 
contributions. My admiration began at that 
moment. Later, when seeking an adviser within 
the modest scientific environment of Argentina, 
our common country of birth, I very much 
wanted Estela to accept that role. Among my 
best memories is of a conversation that took 
place after I, without having made an appoint-
ment, knocked on the door of her laboratory 
in one of the few renowned research institutes 
in Argentina. After listening to my primitive 
ideas for a PhD project, I received the first of 
her “how interesting” comments. Later, I was 
allowed to learn how to do science under her 
supervision. What a pleasure! Over time, we 
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became friends as well as scientific collabor-
ators. She moved back to the United States, 
to work in the Department of Dermatology at 
the University of Cincinnati. In 1995, Estela 
was recruited to Baylor College of Medicine, 
and in 2003 she became a professor in the 
Department of Molecular and Cellular Biology.
Both at a distance and during the several 
times that I visited Estela, we discussed sci-
ence with delight. There was always a shared 
moment of fascination. I sought her opinion on 
all my projects, and I was invariably relieved 
by her approval, which was usually accomp-
anied by the comment: “How interesting!”
Estela’s absence as a scientist and a lovely 
person will be very hard to overcome.
Fernando Larcher
Cutaneous Disease Modeling Unit, Epithelial Biomedicine 
Division, Madrid, Spain
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